Imexpharm Corp
VN:IMP
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
I
|
Imexpharm Corp
VN:IMP
|
VN |
|
I
|
Incyte Corp
XMUN:ICY
|
US |
|
F
|
Frontline Plc
OSE:FRO
|
CY |
|
W
|
Whitehaven Coal Ltd
F:WC2
|
AU |
|
A
|
Ares Strategic Mining Inc
CNSX:ARS
|
CA |
|
C
|
China CYTS Tours Holding Co Ltd
SSE:600138
|
CN |
|
Itausa SA
BOVESPA:ITSA4
|
BR |
|
Cahya Mata Sarawak Bhd
OTC:CHYMF
|
MY |
|
Daehan Shipbuilding Co Ltd
KRX:439260
|
KR |
|
W
|
Wabash National Corp
F:WA9
|
US |
|
S
|
Seri Industrial SpA
LSE:0Q98
|
IT |
|
V
|
Vodafone Group PLC
F:VODI
|
UK |
|
V2X Inc
F:1V1
|
US |
Bankruptcy Probability
Imexpharm Corp's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Imexpharm Corp Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| VN |
I
|
Imexpharm Corp
VN:IMP
|
7.1T VND |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.1T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
567.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Hisamitsu Pharmaceutical Co Inc
TSE:4530
|
70.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
232.9B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
284.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
204.7B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
265.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CA |
|
Nuvo Pharmaceuticals Inc
TSX:MRV
|
334.9B CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.3T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Imexpharm Corp's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Imexpharm Corp has total debt of 212.8B VND. This includes both short-term (112.8B VND) and long-term (100B VND) debt.
You can find a full breakdown on its Balance Sheet.
